News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
225,397 Results
Type
Article (5021)
Company Profile (17)
Press Release (220359)
Section
Business (82212)
Career Advice (461)
Deals (15043)
Drug Delivery (8)
Drug Development (19066)
Employer Resources (30)
FDA (3676)
Job Trends (3901)
News (120121)
Policy (7504)
Tag
Academia (294)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (14778)
ALS (20)
Alzheimer's disease (247)
Antibody-drug conjugate (ADC) (11)
Approvals (3695)
Artificial intelligence (42)
Autoimmune disease (3)
Automation (3)
Bankruptcy (97)
Best Places to Work (2862)
Biosimilars (11)
Biotechnology (21)
Bladder cancer (9)
Brain cancer (7)
Breast cancer (48)
Cancer (459)
Cardiovascular disease (24)
Career advice (393)
Career pathing (3)
CAR-T (32)
Cell therapy (106)
Cervical cancer (2)
Clinical research (16042)
Collaboration (173)
Compensation (170)
Complete response letters (2)
COVID-19 (301)
CRISPR (8)
C-suite (110)
Cystic fibrosis (16)
Data (526)
Depression (6)
Diabetes (43)
Diagnostics (2041)
Digital health (3)
Diversity, equity & inclusion (12)
Drug discovery (15)
Drug pricing (6)
Drug shortages (1)
Duchenne muscular dystrophy (11)
Earnings (40889)
Editorial (2)
Employer branding (6)
Employer resources (31)
Events (37825)
Executive appointments (315)
FDA (3933)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (185)
Gene editing (16)
Generative AI (2)
Gene therapy (53)
GLP-1 (109)
Government (412)
Guidances (18)
Healthcare (5056)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (6)
Infectious disease (317)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (15)
Interviews (53)
IPO (7825)
IRA (3)
Job creations (1121)
Job search strategy (360)
Kidney cancer (7)
Labor market (5)
Layoffs (100)
Leadership (5)
Legal (2332)
Liver cancer (17)
Lung cancer (54)
Lymphoma (31)
Management (10)
Manufacturing (50)
MASH (28)
Medical device (3861)
Medtech (3862)
Mergers & acquisitions (7425)
Metabolic disorders (124)
Multiple sclerosis (8)
NASH (6)
Neurodegenerative disease (11)
Neuropsychiatric disorders (1)
Neuroscience (344)
NextGen: Class of 2025 (1674)
Non-profit (727)
Now hiring (3)
Obesity (53)
Opinion (30)
Ovarian cancer (17)
Pain (13)
Pancreatic cancer (15)
Parkinson's disease (28)
Partnered (4)
Patents (21)
Patient recruitment (32)
Peanut (5)
People (24614)
Pharmaceutical (5)
Pharmacy benefit managers (1)
Phase I (4783)
Phase II (6965)
Phase III (5553)
Pipeline (567)
Policy (9)
Postmarket research (625)
Preclinical (1875)
Press Release (66)
Prostate cancer (27)
Psychedelics (3)
Radiopharmaceuticals (105)
Rare diseases (70)
Real estate (1875)
Recruiting (8)
Regulatory (5123)
Reports (14)
Research institute (301)
Resumes & cover letters (68)
Rett syndrome (4)
Schizophrenia (21)
Series A (28)
Series B (23)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (28)
Sponsored (4)
Startups (1010)
Stomach cancer (1)
Supply chain (10)
Tariffs (5)
Vaccines (39)
Venture capitalists (2)
Weight loss (22)
Women's health (1)
Date
Today (51)
Last 7 days (207)
Last 30 days (696)
Last 365 days (9931)
2025 (3173)
2024 (11035)
2023 (13213)
2022 (18659)
2021 (19680)
2020 (18238)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9157)
2015 (12119)
2014 (9587)
2013 (7707)
2012 (8329)
2011 (8797)
2010 (8634)
Location
Africa (184)
Alabama (13)
Alaska (2)
Arizona (59)
Arkansas (1)
Asia (11461)
Australia (1611)
California (1985)
Canada (713)
China (73)
Colorado (84)
Connecticut (94)
Delaware (30)
Europe (24535)
Florida (284)
Georgia (34)
Idaho (23)
Illinois (116)
India (7)
Indiana (64)
Iowa (2)
Japan (74)
Kansas (24)
Kentucky (10)
Louisiana (5)
Maine (40)
Maryland (226)
Massachusetts (1587)
Michigan (85)
Minnesota (141)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (12)
Nevada (23)
New Hampshire (16)
New Jersey (572)
New Mexico (5)
New York (479)
North Carolina (331)
North Dakota (3)
Northern California (944)
Ohio (59)
Oklahoma (5)
Oregon (4)
Pennsylvania (350)
Puerto Rico (1)
Rhode Island (13)
South America (276)
South Carolina (5)
Southern California (717)
Tennessee (40)
Texas (230)
United States (7173)
Utah (64)
Virginia (46)
Washington D.C. (9)
Washington State (175)
West Virginia (2)
Wisconsin (24)
225,397 Results for "cancervax corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Top Biotech Exec Joins CancerVax as Chief Scientific Advisor
February 27, 2025
·
4 min read
Press Releases
CancerVax Announces Successful Tests of its Smart mRNA Technology
February 25, 2025
·
6 min read
Press Releases
CancerVax Passes First Test with Flying Colors
December 20, 2024
·
6 min read
Press Releases
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
·
5 min read
Press Releases
CancerVax Lands Top Cancer Expert
November 19, 2024
·
3 min read
BioMidwest
CancerVax Launches $5 Million Funding Round
CancerVax, Inc., developer of a breakthrough Universal Cancer Vaccine treatment that will use the body’s immune system to fight cancer, announced that its Reg A+ offering has been qualified by the SEC allowing the Company to formally launch a funding round of up to $5 million.
April 3, 2024
·
3 min read
Biotech Beach
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has achieved a critical milestone by creating a process to add any antibody to lipid nanoparticles using “click chemistry”, for targeting cancer cells.
May 21, 2024
·
4 min read
Policy
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, announced that its UCLA research team has created a promising new drug candidate for treating recurrent Ewing sarcoma, a deadly children’s cancer.
April 16, 2024
·
4 min read
Press Releases
CancerVax Adds Key Members to Its Research Team
August 1, 2024
·
3 min read
Press Releases
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
·
4 min read
1 of 22,540
Next
